Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trials.

GPC can be used to estimate individual Δ which can then be aggregated in a meta-analytic way in N-of-1 trials. GPC ability to easily incorporate patient preferences allow for more personalized treatment evaluation, while needing much less computing time than Bayesian modeling.